Assessing outcomes in probe ablative therapies for small renal masses

Journal of Endourology

Volumn 24, Issue 5, 2010, Pages 759-764

  Leveridge, Michael J ^a   Mattar, Kamal ^a   Kachura, John ^b   Jewett, Michael A S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOABLATION; CRYOTHERAPY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; INFRARED PHOTOGRAPHY; KIDNEY CARCINOMA; KIDNEY TUMOR; MOLECULAR PROBE; NEPHRECTOMY; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL RISK; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME; URETER OBSTRUCTION; URINE INCONTINENCE;

CARCINOMA, RENAL CELL; CATHETER ABLATION; CRYOTHERAPY; HUMANS; KIDNEY NEOPLASMS; TREATMENT OUTCOME;

EID: 77952572985     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0503     Document Type: Review

References (56)

1. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute, 2009. Available at http:==seer.cancer.gov=csr= 1975-2006=.
2. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. Decreasing size at diagnosis of stage 1 renal cell carcinoma: Analysis from the National Cancer Data Base, 1993 to 2004. J Urol 2008;179:2131-2135.
3. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: A meta-analysis. Cancer 2008; 113:2671-2680.
4. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009;115:2844-2852.
5. Nguyen MM, Gill IS. Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol 2009;181:1020-1027; discussion 1027.
6. Kutikov A, Kunkle DA, Uzzo RG. Focal therapy for kidney cancer:Asystematic review. Curr Opin Urol 2009;19:148-153.
7. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature. J Urol 2006;175:425-431.
8. Kassouf W, Siemens R, Morash C, et al. Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma. Can Urol Assoc J 2009;3:73-76.
9. Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998;159:1163-1167.
10. Davenport MS, Caoili EM, Cohan RH, et al. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol 2009;192:1571-1578.
11. Bensalah K, Zeltser I, Tuncel A, Cadeddu J, Lotan Y. Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and laparoscopic partial nephrectomy for treating small renal tumours. BJU Int 2008;101: 467-471.
12. Matsumoto ED, Watumull L, Johnson DB, et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol 2004;172:45-48.
13. Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: Role of CT and MR imaging. Radiographics 2007;27:343-355.
14. Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria RJ. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 2007;27:325-339; discussion 339-340.
15. Raman JD, Stern JM, Zeltser I, Kabbani W, Cadeddu JA. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol 2008;179:2142-2145.
16. Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008;179:1277-1281; discussion 1281-1283.
17. Clark TW, Millward SF, Gervais DA, et al. Reporting standards for percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol 2009;20:S409-S416.
18. Vricella GJ, Ponsky LE, Cadeddu JA. Ablative technologies for urologic cancers. Urol Clin North Am 2009;36:163-178, viii.
19. Sterrett SP, Nakada SY, Wingo MS, Williams SK, Leveillee RJ. Renal thermal ablative therapy. Urol Clin North Am 2008;35:397-414, viii.
20. Pereira PL, Trubenbach J, Schenk M, et al. Radiofrequency ablation: In vivo comparison of four commercially available devices in pig livers. Radiology 2004;232:482-490.
21. Lewin JS, Nour SG, Connell CF, et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: Initial experience. Radiology 2004;232:835-845.
22. Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging 2008;27:421-433.
23. Peters NH, Bartels LW, Sprinkhuizen SM, Vincken KL, Bakker CJ. Do respiration and cardiac motion induce magnetic field fluctuations in the breast and are there implications for MR thermometry? J Magn Reson Imaging 2009; 29:731-735.
24. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185:64-71.
25. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol 2008;81:362-378.
26. Brenner DJ, Hall EJ. Computed tomography-An increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284.
27. Agarwal R, Brunelli SM, Williams K, Mitchell MD, Feldman HI, Umscheid CA. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: A systematic review and meta-analysis. Nephrol Dial Transplant 2009;24:856-863.
28. Ascenti G, Mazziotti S, Zimbaro G, et al. Complex cystic renal masses: Characterization with contrast-enhanced US. Radiology 2007;243:158-165.
29. Fan L, Lianfang D, Jinfang X, Yijin S, Ying W. Diagnostic efficacy of contrast-enhanced ultrasonography in solid renal parenchymal lesions with maximum diameters of 5 cm. J Ultrasound Med 2008;27:875-885.
30. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: Intermediate-term results. J Endourol 2006;20:569-573.
31. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007;189:429-436.
32. Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008;180:499-504; discussion 504.
33. Wyler SF, Sulser T, Ruszat R, et al. Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol 2007;51:971-979.
34. Weld KJ, Figenshau RS, Venkatesh R, et al. Laparoscopic cryoablation for small renal masses: Three-year follow-up. Urology 2007;69:448-451.
35. Lehman DS, Hruby GW, Phillips CK, McKiernan JM, Benson MC, Landman J. First Prize (tie): Laparoscopic renal cryoablation: Efficacy and complications for larger renal masses. J Endourol 2008;22:1123-1127.
36. Aron M, Kazumi K, Haber G, et al. Laparoscopic renal cryoablation: Long-term oncologic outcomes with minimum 5-year follow-up. J Urol 2008;179:209-210.
37. Atwell TD, Farrell MA, Leibovich BC, et al. Percutaneous renal cryoablation: Experience treating 115 tumors. J Urol 2008;179:2136-2140; discussion 2140-2141.
38. Caviezel A, Terraz S, Schmidlin F, Becker C, Iselin CE. Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: Medium-term follow-up. Scand J Urol Nephrol 2008;42:412-416.
39. Finley DS, Beck S, Box G, et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 2008;180: 492-498; discussion 498.
40. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study. J Urol 2006;176:1973-1977.
41. Cadeddu JA, Raman JD. Renal tumor ablation is a function of patient selection and technique-Not the ablation technology. Cancer 2008;113:2623-2626.
42. Dib RE, Touma NJ, Kapoor A. Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Can Urol Assoc J 2009;3:143-149.
43. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer 2004;100:738-745.
44. Lamb GW, Bromwich EJ, Vasey P, Aitchison M. Management of renal masses in patients medically unsuitable for nephrectomy-Natural history, complications, and outcome. Urology 2004;64:909-913.
45. Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 2004;11:2407-2410.
46. Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S. Active surveillance for selected patients with renal masses: Updated results with long-term follow-up. Cancer 2007;110:1010-1014.
47. Wong JA, Rendon RA. Progression to metastatic disease from a small renal cell carcinoma prospectively followed with an active surveillance protocol. Can Urol Assoc J 2007;1:120-122.
48. Fernando HS, Duvuru S, Hawkyard SJ. Conservative management of renal masses in the elderly: Our experience. Int Urol Nephrol 2007;39:203-207.
49. Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA. Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 2002;168:2406-2409; discussion 2409-2410.
50. Rendon RA, Kachura JR, Sweet JM, et al. The uncertainty of radio frequency treatment of renal cell carcinoma: Findings at immediate and delayed nephrectomy. J Urol 2002;167: 1587-1592.
51. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: An analysis of pathological features related to tumor size. J Urol 2003;170:2217-2220.
52. Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 2009;181:2033-2036.
53. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009;182:844-853.
54. Permpongkosol S, Link RE, Kavoussi LR, Solomon SB. Percutaneous computerized tomography guided cryoablation for localized renal cell carcinoma: Factors influencing success. J Urol 2006;176:1963-1968; discussion 1968.
55. Yossepowitch O, Thompson RH, Leibovich BC, et al. Positive surgical margins at partial nephrectomy: Predictors and oncological outcomes. J Urol 2008;179:2158-2163.
56. Bensalah K, Pantuck AJ, Rioux-Leclercq N, et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 2010;57:466-471.